PDL BioPharma names Andrew Guggenhime CFO as of April 3

KatherineHunt

SAN FRANCISCO (MarketWatch) -- PDL BioPharma Inc.
PDLI, -1.89%
said after the closing bell on Tuesday it has named Andrew Guggenhime as chief financial officer, effective April 3. Guggenhime previously served as CFO of Neoforma Inc.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.